CLEARSIDE BIOMEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.29 USD | -3.73% |
|
-8.51% | +10.26% |
| 16/04 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
| 18/03 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Chart calendar Clearside Biomedical, Inc.
421d01ed53eae1232ff384353955.2_czGpwvAQMQRBVN9fRjdIdbVBr_bIM24f7tVLAM12Q.nb90e_9tW3tiF3gUn6IWG8EUG0jGB8VfmK--ZYlfkAy0lX5XrBZCR09xYg~c138b7df969bd9016f344e3bb3ccd0e3
Upcoming events on Clearside Biomedical, Inc.
Past events on Clearside Biomedical, Inc.
| 11/04/2024 12:30 am | Needham Healthcare Conference |
| 13/03/2024 02:00 am | Q4 2023 Earnings Call |
| 13/03/2024 01:35 am | Q4 2023 Earnings Release |
| 15/11/2023 07:05 pm | Stifel Healthcare Conference - Fireside Chat |
| 14/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 07/11/2023 01:24 am | American Academy of Ophthalmology Meeting - Poster No PA069 |
| 06/11/2023 05:39 am | American Academy of Ophthalmology Meeting - Poster No PA051 |
| 04/11/2023 04:23 am | American Academy of Ophthalmology Meeting - Poster No RET10 |
| 03/11/2023 | American Academy Of Ophthalmology Meeting - Poster No PO603 |
| 03/11/2023 | American Academy Of Ophthalmology Meeting - Poster No PO514 |
| 10/10/2023 11:30 pm | JonesTrading Healthcare Summit - Pnnel |
| 26/09/2023 11:40 pm | Cantor Global Healthcare Conference - Panel |
| 16/08/2023 04:30 pm | H.C. Wainwright Ophthalmology Virtual Conference |
| 15/08/2023 02:00 am | Q2 2023 Earnings Call |
| 15/08/2023 01:35 am | Q2 2023 Earnings Release |
| 08/08/2023 12:00 am | BTIG Virtual Biotechnology Conference |
| 31/07/2023 09:30 am | Chardan Virtual Ophthalmology Summit |
| 30/07/2023 09:07 pm | American Society of Retina Specialists Conference |
| 27/07/2023 11:20 pm | Ophthalmology Innovation Source Retina Innovation Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,17 3,27 -33.51% | 7,89 7,59 4.01% | 29,6 21,3 38.65% | 1,33 1,09 21.3% | 8,23 6,13 34.22% | 2,74 |
|
EBITDA Million USD | Released Forecast Spread | -30,1 -32,6 7.7% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -30,3 -30,2 -0.32% | -17,9 -19,3 7.18% | -0,63 -11,8 94.68% | -30,3 -30,0 -1.07% | -24,8 -25,9 4.11% | -35,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,8 -30,9 0.27% | -18,2 -19,5 6.75% | 0,38 -12,3 103.06% | -32,9 -30,8 -6.81% | -32,5 -33,5 2.93% | -39,7 |
|
Net income Million USD | Released Forecast Spread | -30,8 -29,9 -2.84% | -18,2 -16,9 -7.78% | 0,38 -7,28 105.16% | -32,9 -30,8 -6.81% | -32,5 -32,9 1.27% | -39,7 |
|
EPS USD | Released Forecast Spread | -0,81 -0,81 0.49% | -0,39 -0,35 -12.23% | 0,01 -0,16 106.1% | -0,55 -0,51 -7.32% | -0,53 -0,53 0.75% | -0,53 |
| Announcement Date | 11/03/20 | 10/03/21 | 10/03/22 | 09/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 25,7 17,4 47.3% | 0,35 6,20 -94.4% | 0,38 0,30 28% | 0,27 0,02 1082.22% | 0,33 0,10 244.47% | 0,00 0,06 -93.33% | 1,02 0,07 1402.58% | 0,86 0,13 549.77% | 6,35 4,24 49.65% | 0,68 | 0,68 | 0,69 | 0,69 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 18,7 7,22 159.13% | -7,65 -0,82 -829.04% | -7,84 -7,72 -1.52% | -6,72 -8,34 19.35% | -8,07 -7,75 -4.11% | -7,61 -7,90 3.78% | -7,27 -8,28 12.22% | -7,05 -8,50 17% | -2,92 -3,99 26.89% | -8,56 | -8,72 | -8,50 | -8,60 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 18,7 6,28 197.82% | -7,64 1,11 -788.65% | -7,81 -7,81 -0.07% | -7,83 -8,34 6.1% | -9,66 -7,56 -27.86% | -9,28 -8,57 -8.27% | -9,11 -8,62 -5.69% | -9,27 -9,55 2.95% | -4,83 -5,80 16.69% | -9,96 | -10,1 | -9,93 | -10,0 | |
|
Net income Million USD | Released Forecast Spread | 18,7 9,08 106.15% | -7,64 -0,39 -1843.41% | -7,81 -8,04 2.86% | -7,83 -8,50 7.93% | -9,66 -7,56 -27.86% | -9,28 -8,57 -8.27% | -9,11 -8,74 -4.14% | -9,27 -9,32 0.61% | -4,83 -5,24 7.79% | -10,0 | -10,2 | -9,90 | -9,80 | |
|
EPS USD | Released Forecast Spread | 0,31 0,15 103.95% | -0,13 -0,12 -11.43% | -0,13 -0,14 3.7% | -0,13 -0,14 7.14% | -0,16 -0,12 -30.61% | -0,15 -0,14 -7.14% | -0,15 -0,14 -4.65% | -0,15 -0,15 -1.69% | -0,08 -0,09 6.98% | -0,14 | -0,14 | -0,13 | -0,12 | -0,11 |
| Announcement Date | 10/03/22 | 11/05/22 | 09/08/22 | 09/11/22 | 09/03/23 | 12/05/23 | 14/08/23 | 13/11/23 | 12/03/24 | - | - | - | - | - |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Clearside Biomedical, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLSD Stock
- Calendar Clearside Biomedical, Inc.
